Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
September 28, 2020

GSK gets FDA approval for Nucala to treat hypereosinophilic syndrome

GlaxoSmithKline (GSK) has secured approval from the US Food and Drug Administration (FDA) for its Nucala (mepolizumab) for the treatment of hypereosinophilic syndrome (HES), a rare and under-diagnosed disorder.

Continue
GSK's corporate headquarters in Brentford, London. (Credit: SmugMug+Flickr / GlaxoSmithKline plc)
September 28, 2020

J&J, GRAM collaborate on manufacturing of Covid-19 vaccine candidate

J&J and GRAM have collaborated on manufacturing of COVID-19 vaccine candidate. (Credit: Aneta Esz from Pixabay)
September 23, 2020

Sinovac begins Covid-19 vaccine candidate trials in Turkey

Sinovac has commenced Covid-19 vaccine candidate trials in Turkey. (Credit: Gerd Altmann from Pixabay)

Contracts

September 23, 2020

Sanofi, GSK sign agreements with Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine

Sanofi and GSK have signed agreements with the Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine. (Credit: Pete Linforth from Pixabay)

Sanofi, GSK sign deal to supply 300 million doses of Covid-19 vaccine in EU states

Catalent to expand manufacturing for Covid-19 vaccine candidate AZD1222

Pfizer, BioNTech sign $1.95bn deal with US govt for supply of Covid-19 vaccine candidate

Deals

Deals September 22, 2020

Roche acquires Irish biotechnology company Inflazome for €380m

Pharmaceutical Business Review

Vifor Pharma Group announces successful sale of OM Pharma

Santen and US ophthalmic company Eyevance enter into share purchase agreement

AstraZeneca acquires Dogma’s oral PCSK9 inhibitor programme

Popular

  1. OncoImmune’s SACCOVID demonstrates significant therapeutic efficacy in Covid-19 trial
  2. J&J begins phase 3 trial of Covid-19 vaccine candidate JNJ-78436735
  3. BMS, bluebird get FDA priority review for ide-cel in multiple myeloma
  4. Opdivo delivers significant OS and PFS benefits in CheckMate -649 trial
  5. PADCEV succeeds in confirmatory phase 3 trial in urothelial cancer

PRESS RELEASES

Pharmaceutical Business Review
Development and Production of the Respimat® Reuseable Inhaler Housing Module
Ensuring regulatory compliance with Brenntag Specialities
Ensuring regulatory compliance with Brenntag Specialities
New laboratory and regulatory services for biotech customers
New laboratory and regulatory services for biotech customers
Pharmaceutical Business Review
Upcoming NSF Webinar: Nitrosamine Impurities; What’s the Impact on IMPs
Enamine Released Coronavirus Library to Support COVID-19 Research Programs
Enamine Released Coronavirus Library to Support COVID-19 Research Programs

Suppliers

Whitepapers

Self-Assessment on Nitrosamine Risk Exposure
Self-Assessment on Nitrosamine Risk Exposure
gem-Difluorinated Amines for Drug Design
gem-Difluorinated Amines for Drug Design
eSource Arising: Clinical Data Automation Possibilities Beyond Data Capture
eSource Arising: Clinical Data Automation Possibilities Beyond Data Capture